Microsoft has discontinued support for Internet Explorer. To access the Tarter website, please install a modern browser like Microsoft Edge or Google Chrome.
This website does not track your personal or demographic information, only anonymous usage statistics. To ensure that you are not tracked, we have blocked all embedded content from third party sources like YouTube and SlideShare. Click "Accept Cookies" to enable third-party content. To learn more about our cookie policy,click here.
Tarter Krinsky & Drogin’s Bankruptcy and Corporate Restructuring co-chair Scott Markowitz has been retained as bankruptcy counsel to the Ad Hoc Committee of NAS Babies in the Purdue Pharma Chapter 11 case pending in the United States Bankruptcy Court for the Southern District of New York. Since 2012, more than 300,000 babies have been born in the United States with Neonatal Abstinence Syndrome (NAS), which stems from opioid-dependent mothers. NAS is a group of conditions caused when a baby withdraws from opioids when exposed in the womb before birth, and have numerous developmental issues and have to be weaned off of opioids after birth.
Purdue marketed OxyContin, one of the most powerful opioids, and the Chapter 11 was filed to try and implement a global settlement of all lawsuits by setting up a trust of approximately $15 billion of which $3 billion will be contributed by the Sackler family, the owners of Purdue.